Universität zu Köln

2018

Kriz, J., Baues, C., Oertel, M., Engenhart-Cabillic, R., Herfarth, K., Lukas, P., Marnitz-Schulze, S., Schmidberger, H., Vordermark, D., Haverkamp, U., Engert, A. and Eich, H. (2018). First Results of Quality Control of Involved Node Radiotherapy within the HD17-Study of the German Hodgkin Study Group (GHSG). Strahlenther. Onkol., 194. S. S14 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

2017

Kriz, J., Baues, C., Engenhart-Cabillic, R., Haverkamp, U., Herfart, K., Lukas, P., Pluetschow, A., Schmidberger, H., Staar, S., Fuchs, M., Engert, A. and Eich, H. T. (2017). Quality control of involved field radiotherapy in the HD 13 and HD 14 trials. Strahlenther. Onkol., 193 (2). S. 109 - 116. MUNICH: URBAN & VOGEL. ISSN 1439-099X

Kriz, J., Baues, C., Engenhart-Cabillic, R., Haverkamp, U., Herfarth, K., Lukas, P., Schmidberger, H., Marnitz-Schulze, S., Fuchs, M., Engert, A. and Eich, H. T. (2017). New quality assurance program integrating modern radiotherapy within the German Hodgkin Study Group. Strahlenther. Onkol., 193 (2). S. 100 - 109. MUNICH: URBAN & VOGEL. ISSN 1439-099X

2016

Eich, H. T., Kriz, J., Engenhart-Cabillic, R., Haverkamp, U., Herfarth, K., Lukas, P., Schmidberger, H., Staar, S., Pluetschow, A., Fuchs, M., Engert, A. and Baues, C. (2016). FINAL RESULTS OF A QUALITY ASSURANCE PROGRAM WITHIN THE GERMAN HODGKIN STUDY GROUP HD13/14 TRIAL - A REPORT FROM THE RADIOTHERAPY REFERENCE PANEL INTEGRATING MODERN GUIDELINES. Haematologica, 101. S. 14 - 15. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

2015

Kobe, C., Kuhnert, G., Haverkamp, H., Fuchs, M., Kahraman, D., Eich, H. -T., Kriz, J., Baues, C., Nast-Kolb, B., Broeckelmann, P. J., Borchmann, P., Drzezga, A., Engert, A. and Dietlein, M. (2015). Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma. Nuklearmedizin, 54 (6). S. 241 - 247. STUTTGART: GEORG THIEME VERLAG KG. ISSN 2567-6407

Kriz, J., Engenhart-Cabillic, R., Haverkamp, U., Herfarth, K., Lukas, P., Schmidberger, H., Staar, S., Engert, A. and Eich, H. (2015). Establishment of a new Quality Assurance Program in Age of modern Radiotherapy as Part of the German Hodgkin Study Group. Strahlenther. Onkol., 191. S. S165 - 1. MUNICH: URBAN & VOGEL. ISSN 1439-099X

Kriz, J., Engenhart-Cabillic, R., Haverkamp, U., Herfarth, K. K., Lukas, P., Schmidberger, H., Staar, S., Engert, A. and Eich, H. (2015). Establishing a New Quality Assurance Program of Modern Radiation Therapy Within the German Hodgkin Study Group. Int. J. Radiat. Oncol. Biol. Phys., 93 (3). S. E454 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X

Kriz, J., Pluetschow, A., Engenhart-Cabillic, R., Herfarth, K., Lukas, P., Schmidberger, H., Staar, S., Haverkamp, U., Baues, C., Engert, A. and Eich, H. (2015). Analysis of the Quality Assurance Program of the Involved Field Radiotherapy within the HD13 and HD14 Study the German Hodgkin Study Group. Strahlenther. Onkol., 191. S. S10 - 2. MUNICH: URBAN & VOGEL. ISSN 1439-099X

Kriz, J., Pluetschow, A., Engenhart-Cabillic, R., Herfarth, K. K., Lukas, P., Schmidberger, H., Staar, S., Haverkamp, U., Baues, C., Engert, A. and Eich, H. (2015). Quality Assurance of Involved Field Radiation Therapy Within the HD13 and HD14 Trial (early stages) of the German Hodgkin Study Group. Int. J. Radiat. Oncol. Biol. Phys., 93 (3). S. E449 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X

2013

Eich, H. T., Kriz, J., Reinartz, G., Kobe, C., Kuhnert, G., Haverkamp, U., Haverkamp, H., Hegerfeld, K., Baues, C. and Engert, A. (2013). Relapse Analysis After Radiation Therapy of PET-Positive Residual Tumors of Patients With Advanced Stage Hodgkin Lymphoma Treated in the HD15 Trial of the German Hodgkin Study Group (GHSG). Int. J. Radiat. Oncol. Biol. Phys., 87 (2). S. S5 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X

2012

Eich, H. T., Kriz, J., Klimm, B., Sasse, S., Goergen, H., Diehl, V., Borchmann, P., Mueller, R. and Engert, A. (2012). Involved-field (IF) Versus Extended-field (EF) Radiation Therapy (RT) for Patients in Early Unfavorable Stages of Hodgkin Lymphoma: 10-year Update of the HD8 Trial of the German Hodgkin Study Group (GHSG). Int. J. Radiat. Oncol. Biol. Phys., 84 (3). S. S70 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 0360-3016

Kriz, J., Mueller, R. -P., Mueller, H., Kuhnert, G., Engert, A., Kobe, C., Haverkamp, U. and Eich, H. T. (2012). Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma Is the definition on the basis of a chest radiograph in the era of CT obsolete? Strahlenther. Onkol., 188 (11). S. 1020 - 1025. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

2011

Kobe, C., Dietlein, M., Borchmann, P., Engert, A., Kuhnert, G., Fuchs, M., Haverkamp, H., Eich, H. T., Kriz, J. and Diehl, V. (2011). PET-Response Adapted Therapy in Hodgkin Lymphoma. Eur. J. Cancer, 47. S. S16 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 0959-8049